Patents by Inventor Gerhard Nossner

Gerhard Nossner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Disease treatment with novel phospholipid derivatives
    Patent number: 6903080
    Abstract: A method of treating protozoal and fungal diseases is described, in which an effective amount of a compound of formula I is administered to a host having a protozoal or fungal disease.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: June 7, 2005
    Assignee: Zentaris GmbH
    Inventors: Gerhard Nossner, Bernhard Kutscher, Jurgen Engel, Wolfgang Schumacher, Margrit Stekar, Peter Hilgard, Jurij Stekar
  • Novel phospholipid derivatives
    Publication number: 20030153533
    Abstract: Novel phospholipid derivatives of the General Formula I: 1
    Type: Application
    Filed: November 8, 2002
    Publication date: August 14, 2003
    Applicant: Zentaris AG
    Inventors: Gerhard Nossner, Bernhard Kutscher, Jurgen Engel, Wolfgang Schumacher, Jurij Stekar, Peter Hilgard
  • Process for the preparation of alkylphosphocholines and the production thereof in pure form
    Patent number: 6028209
    Abstract: A process for the preparation of C.sub.14 -C.sub.18 -alkylphosphocholines by reacting an n-alkanol with a chain length of C.sub.14 -C.sub.18 with phosphorus oxychloride in an inert solvent or also without solvent in the presence or absence of a basic substance in a single vessel process and subsequent reaction of the reaction product in an inert solvent with a choline salt in the presence of a basic substance to form phosphoric acid diester chloride, subsequent hydrolysis and isolation of alkylphosphocholine as well as optionally purification using a mixed-bed ion exchanger or in successive steps with an acid ion exchanger and a basic ion exchanger.
    Type: Grant
    Filed: April 22, 1999
    Date of Patent: February 22, 2000
    Assignee: Asta Medica AG
    Inventors: Jurgen Engel, Bernd Kutscher, Wolfgang Schumacher, Ulf Niemeyer, Alfred Olbrich, Gerhard Nossner
  • Phospholipid derivatives containing higher elements of the fifth main group
    Patent number: 5958906
    Abstract: Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: September 28, 1999
    Assignee: ASTA-Medica Aktiengesellschaft
    Inventors: Gerhard Nossner, Jurij Stekar, deceased, Peter Hilgard, Bernhard Kutscher, Jurgen Engel
  • Phospholipid derivatives containing higher elements of the fifth group
    Patent number: 5637577
    Abstract: Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: June 10, 1997
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Gerhard Nossner, Jurij Stekar, Peter Hilgard, Bernhard Kutscher, Jurgen Engel
  • Phospholipid derivatives containing higher elements of the fifth group
    Patent number: 5449798
    Abstract: Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives.
    Type: Grant
    Filed: September 22, 1993
    Date of Patent: September 12, 1995
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Gerhard Nossner, Jurij Stekar, Peter Hilgard, Bernhard Kutscher, Jurgen Engel
  • Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation
    Patent number: 5219866
    Abstract: Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation. This compound is useful for the treatment of cancer.
    Type: Grant
    Filed: July 1, 1992
    Date of Patent: June 15, 1993
    Assignee: Asta Medica AG
    Inventors: Wolfgang Schumacher, Jurgen Engel, Gerhard Nossner, Bernhard Kutscher, Jurij Stekar, Peter Hilgard